Timothy Cripe
Program Director · Nationwide Children's Hospital
Credentials: · · · ·
History
- Present
Oncology & BMT Division · Nationwide Children's Hospital
- Present
Division of Hematology/Oncology & BMT · Nationwide Children's Hospital
Research
Journal of Biological Chemistry · 1984 · 432 citations
The EMBO Journal · 1987 · First of 9 authors · 318 citations
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors
Journal of Clinical Investigation · 2013 · 282 citations
15 papers · 2 as a fellow
14 papers
- YM
14 papers · 1 as a resident
13 papers
13 papers
- KH
10 papers
9 papers
9 papers · 4 as a fellow
Grants
- 2024–2029
A New Paradigm to Prevent and Treat Micrometastases
National Cancer Institute · R01
Contact PI · $1.5M · Research Inst Nationwide Children's Hosp
- 2022–2027
Training Program in Basic and Translational Pediatric Oncology Research
National Cancer Institute · T32
Contact PI · $1.8M · Research Inst Nationwide Children's Hosp
- 2019–2025
Novel Immunomodulation and Facilitation of “Suppression Proof” CAR NK Cell Against Ewing Sarcoma
National Cancer Institute · U54
Contact PI · $12.1M · Research Inst Nationwide Children's Hosp
- 2019–2022
An Innovative Modular Strategy for Highly Specific Elimination of Human Osteosarcomas
National Cancer Institute · R21
PI · $381.1K · Ohio State University
Clinical trials
- 2010–2014
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients
Principal investigator · Completed · Phase 1
Jennerex Biotherapeutics
- 2010–2018
HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors
Study director · Completed · Phase 1
Timothy Cripe